Email

jones@bcm.edu

Positions

Associate Professor

Medicine-Athero & Lipo
Baylor College of Medicine
Houston, TX US

Addresses

Center for Cardiovacular Disease Prevention (Clinic)

6655 Travis St Suite 320
Houston, TX 77030
United States
Phone: (713) 798-5800

Education

Internal Medicine residency from Baylor College Of Medicine Affiliate Hospitals

06/1981 - Houston, TX United States

M.D. from Baylor College Of Medicine

01/1977 - Houston, TX United States

B.S. from Washington & Lee University

01/1974 - Lexington, VA United States

Certifications

Internal Medicine

American Board of Internal Medicine

Honors & Awards

Chief Science Officer

National Lipid Association (05/2013 - 05/2020)

Professional Interests

• Clinical research interests

Professional Statement

I have had a long interest in the role that lipoproteins play in causing atherosclerotic vascular disease. My career at Baylor has focused on both the clinical research into new therapies for dyslipidemia and in the management of challenging dyslipidemias in high risk patients. I have also been involved in the medical management of obesity as another method to reduce the metabolic risks associated with vascular disease.

Websites

Selected Publications

• Negi SI, Brautbar A, Virani SS, Anand A, Polisecki E, Asztalos BF, Ballantyne CM, Schaefer EJ, Jones PH "A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier Disease." J Clin Lipidol. 2013;7:82-87.
• Friedewald VE, Ballantyne CM, Bays HE, Jones PH "Editor's Roundtable: Hypertriglyceridemia." Am J Cardiol. 2013;112:1133-1141.
• Brautbar A, Virani SS, Belmont J, Nambi V, Jones PH, Ballantyne CM "LPL gene variants affect apo CIII response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia." J Lipid Res. 2012;53:556-560.
• Brautbar A, Covarrubias D, Belmont J, Lara-Garduno F, Virani SS, Jones PH, Leal SM, Ballantyne CM "Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.." Atherosclerosis. 2011 Dec;219(2):737-42. Pubmed PMID: 21889769